Wang Ben, Wang Ran, Wu Xueling, Zhong Yu, Huang Chaowang, Xu Zhi, Guo Liang
Department of Obstetrics and Gynecology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China.
Front Pharmacol. 2025 Sep 9;16:1552034. doi: 10.3389/fphar.2025.1552034. eCollection 2025.
This study was aimed at identifying the effects of liver X receptor alpha (LXRα) on sepsis-induced acute lung injury (ALI) and clarifying its novel regulatory mechanisms using bioinformatics and experimental methods.
Bioinformatics analysis of the differentially expressed genes and functional annotations were performed. Lipopolysaccharide (LPS) was administered intraperitoneally for sepsis-induced ALI in a mouse model; then, the LXR agonist T0901317 (T0) was administered to the mice along with RAW264.7 macrophages for LXRα activation. We then performed hematoxylin and eosin staining, estimated the total protein in the bronchoalveolar lavage fluid, and detected the expressions of TNFα and IL6 by reverse transcription polymerase chain reaction to evaluate the inflammatory injury in the lung tissues. Autophagy was detected via immunohistochemistry, transmission electron microscopy, and Western blotting. RNA sequencing was then used to analyze the autophagy-related genes regulated by LXRα, and the cells were transfected with S100A8-siRNA to determine whether LXRα regulated inflammatory damage by regulating the autophagy-related gene S100A8. The clinical correlation between LXRα and S100A8 was determined through analysis of human transcriptome data.
The bioinformatics analyses revealed that LXRα (NR1H3) was downregulated in sepsis-induced ALI models and that LXRα might regulate autophagy. The animal- and cell-based experiments further verified these findings. The LXR agonist T0 was found to alleviate lung damage and reduce the expressions of inflammatory factors in the lung tissues and cells. After inhibiting autophagy with 3-methyladenine, the protective effects of T0 on inflammatory damage were shown to be inhibited. Subsequently, RNA sequencing of the macrophages was performed, and four genes (, , , and ) were obtained by intersection of the upregulated and downregulated differential genes with the autophagy gene set. However, among these genes, only that was increased in ALI and decreased markedly after T0 treatment exhibited a negative correlation with T0. Following knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. Analysis of the human transcriptome data revealed a significant negative correlation between LXRα and S100A8 (R = -0.98, < 0.001).
The findings of this study suggest that T0 attenuates sepsis-induced pulmonary injury by promoting macrophage autophagy via suppression of S100A8 expression.
本研究旨在确定肝脏X受体α(LXRα)对脓毒症诱导的急性肺损伤(ALI)的影响,并使用生物信息学和实验方法阐明其新的调控机制。
进行差异表达基因的生物信息学分析和功能注释。在小鼠模型中腹腔注射脂多糖(LPS)以诱导脓毒症ALI;然后,将LXR激动剂T0901317(T0)与RAW264.7巨噬细胞一起给予小鼠以激活LXRα。随后进行苏木精和伊红染色,估计支气管肺泡灌洗液中的总蛋白,并通过逆转录聚合酶链反应检测TNFα和IL6的表达,以评估肺组织中的炎症损伤。通过免疫组织化学、透射电子显微镜和蛋白质印迹法检测自噬。然后使用RNA测序分析受LXRα调控的自噬相关基因,并将细胞用S100A8-siRNA转染,以确定LXRα是否通过调节自噬相关基因S100A8来调节炎症损伤。通过分析人类转录组数据确定LXRα与S100A8之间的临床相关性。
生物信息学分析显示,在脓毒症诱导的ALI模型中LXRα(NR1H3)表达下调,且LXRα可能调节自噬。基于动物和细胞的实验进一步验证了这些发现。发现LXR激动剂T0可减轻肺损伤,并降低肺组织和细胞中炎症因子的表达。用3-甲基腺嘌呤抑制自噬后,T0对炎症损伤的保护作用被抑制。随后对巨噬细胞进行RNA测序,通过上调和下调差异基因与自噬基因集的交集获得四个基因(、、和)。然而,在这些基因中,只有在ALI中增加且在T0处理后明显降低的与T0呈负相关。在用S100A8-siRNA敲低巨噬细胞中的后,发现与用LPS+T0处理的细胞相比,用T0+LPS+S100A8-siRNA处理的细胞中IL-6表达降低。对人类转录组数据的分析显示LXRα与S100A8之间存在显著负相关(R = -0.98,<0.001)。
本研究结果表明,T0通过抑制S100A8表达促进巨噬细胞自噬,从而减轻脓毒症诱导的肺损伤。